Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: betty moyers who wrote (13581)	8/18/1998 1:24:00 PM
From: VLAD	Read Replies (1) \| Respond to of 23519

betty, A few more points to consider: Everything I have read thus far and the few contacts I have had from Astra have been very positive. Astra is an extremely conservative company and usually only makes conservative statements. Astra told me that they did not feel threatened by Viagra and planned on capitalizing of the increased awareness. They also told me that the safety profile of MUSE vs Viagra would be their key selling point. As I stated before, a well known German cardiologist will soon be presenting a paper that will be very damaging to Viagra and its safety profile. I still thing the liability issues surrounding Pfizer will either restrict its sale or pull it. I have just seen too many other drugs pulled with much fewer safety problems. I also was told that 3 wrongful death lawsuits have been filed against Pfizer due to Viagra. The safety issues seem to be mentioned by the media about once a week and then we here nothing for a while. This will eventually come to a head and when it does the Vivus shareholder will be given back what was taken due to Viagra. Again the question is how long. The tuna predicted 6 months. October is near.